Marilyn J. Aardema, PhD Joins BioReliance Corporation as Chief Scientific Officer, Toxicology
11/15/2010 11:26:44 AM
ROCKVILLE, Md.--(BUSINESS WIRE)--BioReliance announced today that Marilyn J. Aardema, PhD has been named Chief Scientific Officer, Toxicology, to provide oversight for all scientific and regulatory aspects of the Company’s Toxicology division. She reports to the President and CEO, Charles C. Harwood, Jr.
comments powered by